With a high population density and over 45% of the global breast cancer incidence, Asia is expected to account for more than half of all TNBC cases, with a large TNBC patient pool, particularly in China and India.

기타 관련 콘텐츠

12/18, 2025 기사

In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”

...

자세히 알아보세요